☰

Sravan K Jonnalagadda - Publications

Affiliations: 
University of Minnesota Duluth, Duluth, MN, United States 
Area:
Chemistry, Medicinal chemistry
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Maddeboina K, Jonnalagadda SK, Morsy A, Duan L, Chhonker YS, Murry DJ, Penning TM, Trippier PC. Aldo-Keto Reductase 1C3 Inhibitor Prodrug Improves Pharmacokinetic Profile and Demonstrates In Vivo Efficacy in a Prostate Cancer Xenograft Model. Journal of Medicinal Chemistry. PMID 37428858 DOI: 10.1021/acs.jmedchem.3c00732  0.367
2023 Huwaimel BI, Jonnalagadda SK, Jonnalagadda S, Kumari S, Nocentini A, Supuran CT, Trippier PC. Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold. Drug Development Research. PMID 36872587 DOI: 10.1002/ddr.22049  0.766
2022 Huwaimel BI, Jonnalagadda S, Jonnalagadda S, Zahra FT, Nocentini A, Supuran CT, Mikelis CM, Trippier PC. Chlorinated benzothiadiazines inhibit angiogenesis through suppression of VEGFR2 phosphorylation. Bioorganic & Medicinal Chemistry. 67: 116805. PMID 35635929 DOI: 10.1016/j.bmc.2022.116805  0.806
2022 Jonnalagadda SK, Huwaimel BI, Jonnalagadda S, Garrison JC, Trippier PC. Access to Highly Strained Tricyclic Ketals Derived from Coumarins. The Journal of Organic Chemistry. 87: 4476-4482. PMID 35258961 DOI: 10.1021/acs.joc.2c00018  0.755
2021 Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Schumacher TJ, Gardner ZS, Palle H, Mani C, Rumbley J, Mereddy VR. Synthesis and biological evaluation of N, N-dialkylcarboxy coumarin-NO donor conjugates as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 128411. PMID 34626786 DOI: 10.1016/j.bmcl.2021.128411  0.822
2021 Penning TM, Jonnalagadda S, Trippier PC, Rižner TL. Aldo-Keto Reductases and Cancer Drug Resistance. Pharmacological Reviews. 73: 1150-1171. PMID 34312303 DOI: 10.1124/pharmrev.120.000122  0.312
2021 Ronayne CT, Jonnalagadda SK, Jonnalagadda S, Nelson GL, Solano LN, Palle H, Mani C, Rumbley J, Holy J, Mereddy VR. Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53. Biochemical and Biophysical Research Communications. 562: 127-132. PMID 34051576 DOI: 10.1016/j.bbrc.2021.05.062  0.821
2020 Solano LN, Nelson GL, Ronayne CT, Jonnalagadda S, Jonnalagadda SK, Kottke K, Chitren R, Johnson JL, Pandey MK, Jonnalagadda SC, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents. Scientific Reports. 10: 17969. PMID 33087745 DOI: 10.1038/s41598-020-74572-1  0.828
2020 Jonnalagadda SK, Wielenberg K, Ronayne CT, Jonnalagadda S, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and biological evaluation of arylphosphonium-benzoxaborole conjugates as novel anticancer agents. Bioorganic & Medicinal Chemistry Letters. 30: 127259. PMID 32527557 DOI: 10.1016/J.Bmcl.2020.127259  0.825
2020 Sadeghzadeh M, Wenzel B, Gündel D, Deuther-Conrad W, Toussaint M, Moldovan RP, Fischer S, Ludwig FA, Teodoro R, Jonnalagadda S, Jonnalagadda SK, Schüürmann G, Mereddy VR, Drewes LR, Brust P. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules (Basel, Switzerland). 25. PMID 32423056 DOI: 10.3390/Molecules25102309  0.783
2019 Nelson GL, Ronayne CT, Solano LN, Jonnalagadda SK, Jonnalagadda S, Rumbley J, Holy J, Rose-Hellekant T, Drewes LR, Mereddy VR. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment. Scientific Reports. 9: 18266. PMID 31797891 DOI: 10.1038/S41598-019-54709-7  0.822
2019 Jonnalagadda S, Jonnalagadda SK, Ronayne CT, Nelson GL, Solano LN, Rumbley J, Holy J, Mereddy VR, Drewes LR. Novel N,N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors. Oncotarget. 10: 2355-2368. PMID 31040927 DOI: 10.18632/Oncotarget.26760  0.829
2019 Sadeghzadeh M, Moldovan RP, Fischer S, Wenzel B, Ludwig FA, Teodoro R, Deuther-Conrad W, Jonnalagadda S, Jonnalagadda SK, Gudelis E, Šačkus A, Higuchi K, Ganapathy V, Mereddy VR, Drewes LR, et al. Development and radiosynthesis of the first F-labeled inhibitor of monocarboxylate transporters (MCTs). Journal of Labelled Compounds & Radiopharmaceuticals. PMID 31017677 DOI: 10.1002/Jlcr.3739  0.775
2018 Nelson GL, Williams MJ, Jonnalagadda S, Alam MA, Mereddy G, Johnson JL, Jonnalagadda SK. Synthesis and Evaluation of Baylis-Hillman Reaction Derived Imidazole and Triazole Cinnamates as Antifungal Agents. International Journal of Medicinal Chemistry. 2018: 5758076. PMID 30410798 DOI: 10.1155/2018/5758076  0.839
2017 Ronayne CT, Solano LN, Nelson GL, Lueth EA, Hubbard SL, Schumacher TJ, Gardner ZS, Jonnalagadda SK, Gurrapu S, Holy J, Mereddy VR. Synthesis and biological evaluation of 2-alkoxycarbonylallyl esters as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. PMID 28129978 DOI: 10.1016/J.Bmcl.2017.01.037  0.803
2016 Alam MA, Arora K, Gurrapu S, Jonnalagadda SK, Nelson GL, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents. Tetrahedron. 72: 3795-3801. PMID 27642196 DOI: 10.1016/J.Tet.2016.03.038  0.829
2016 Gurrapu S, Jonnalagadda SK, Alam MA, Ronayne CT, Nelson GL, Solano LN, Lueth EA, Drewes LR, Mereddy VR. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. PMID 27241692 DOI: 10.1016/J.Bmcl.2016.05.054  0.797
2016 Alam MA, Arora K, Gurrapu S, Jonnalagadda SK, Nelson GL, Kiprof P, Jonnalagadda SC, Mereddy VR. Synthesis and evaluation of functionalized benzoboroxoles as potential anti-tuberculosis agents Tetrahedron. DOI: 10.1016/j.tet.2016.03.038  0.83
2015 Solano LN, Nelson GL, Ronayne CT, Lueth EA, Foxley MA, Jonnalagadda SK, Gurrapu S, Mereddy VR. Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 25: 5777-80. PMID 26561365 DOI: 10.1016/J.Bmcl.2015.10.061  0.801
2015 Gurrapu S, Jonnalagadda SK, Alam MA, Nelson GL, Sneve MG, Drewes LR, Mereddy VR. Monocarboxylate transporter 1 inhibitors as potential anticancer agents. Acs Medicinal Chemistry Letters. 6: 558-61. PMID 26005533 DOI: 10.1021/Acsmedchemlett.5B00049  0.844
Show low-probability matches.